Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Scott & White Memorial Hospital
mi
from
Temple, TX
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Scott & White Memorial Hospital
mi
from
Temple, TX
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Saint Vincent Hospital
mi
from
Green Bay, WI
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Saint Vincent Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
UW Cancer Center Johnson Creek
mi
from
Johnson Creek, WI
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
UW Cancer Center Johnson Creek
mi
from
Johnson Creek, WI
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Dean Hematology And Oncology Clinic
mi
from
Madison, WI
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Dean Hematology And Oncology Clinic
mi
from
Madison, WI
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Holy Family Memorial Hospital
mi
from
Manitowoc, WI
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Holy Family Memorial Hospital
mi
from
Manitowoc, WI
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Bay Area Medical Center
mi
from
Marinette, WI
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Bay Area Medical Center
mi
from
Marinette, WI
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Cancer Center of Western Wisconsin
mi
from
New Richmond, WI
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Cancer Center of Western Wisconsin
mi
from
New Richmond, WI
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Presbyterian - Saint Lukes Medical Center - Health One
mi
from
Denver, CO
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Presbyterian - Saint Lukes Medical Center - Health One
mi
from
Denver, CO
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
SCL Health Saint Joseph Hospital
mi
from
Denver, CO
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
SCL Health Saint Joseph Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Colorado Cancer Research Program NCORP
mi
from
Denver, CO
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Colorado Cancer Research Program NCORP
mi
from
Denver, CO
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Saint Anthony Hospital
mi
from
Lakewood, CO
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Saint Anthony Hospital
mi
from
Lakewood, CO
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
SCL Health Lutheran Medical Center
mi
from
Wheat Ridge, CO
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
SCL Health Lutheran Medical Center
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Smilow Cancer Hospital Care Center at Saint Francis
mi
from
Hartford, CT
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Smilow Cancer Hospital Care Center at Saint Francis
mi
from
Hartford, CT
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
mi
from
Savannah, GA
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
mi
from
Savannah, GA
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Saint Alphonsus Cancer Care Center-Boise
mi
from
Boise, ID
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Saint Alphonsus Cancer Care Center-Boise
mi
from
Boise, ID
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Saint Joseph Medical Center
mi
from
Bloomington, IL
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Saint Joseph Medical Center
mi
from
Bloomington, IL
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Heartland Cancer Research NCORP
mi
from
Decatur, IL
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Heartland Cancer Research NCORP
mi
from
Decatur, IL
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Illinois CancerCare-Galesburg Cottage Plaza Office
mi
from
Galesburg, IL
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Illinois CancerCare-Galesburg Cottage Plaza Office
mi
from
Galesburg, IL
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Community Cancer Center Foundation
mi
from
Normal, IL
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Community Cancer Center Foundation
mi
from
Normal, IL
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Ottawa Regional Hospital and Healthcare Center
mi
from
Ottawa, IL
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Ottawa Regional Hospital and Healthcare Center
mi
from
Ottawa, IL
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center
mi
from
Pekin, IL
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
OSF Saint Francis Radiation Oncology at Pekin Cancer Treatment Center
mi
from
Pekin, IL
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
OSF Saint Francis Medical Center
mi
from
Peoria, IL
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
OSF Saint Francis Medical Center
mi
from
Peoria, IL
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Illinois Valley Hospital
mi
from
Peru, IL
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Illinois Valley Hospital
mi
from
Peru, IL
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
SwedishAmerican Regional Cancer Center/ACT
mi
from
Rockford, IL
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
SwedishAmerican Regional Cancer Center/ACT
mi
from
Rockford, IL
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Carle Cancer Center
mi
from
Urbana, IL
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Indiana University Melvin and Bren Simon Cancer Center
mi
from
Indianapolis, IN
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Indiana University Melvin and Bren Simon Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Sidney and Lois Eskenazi Hospital
mi
from
Indianapolis, IN
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Sidney and Lois Eskenazi Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Franciscan Saint Anthony Health-Michigan City
mi
from
Michigan City, IN
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Franciscan Saint Anthony Health-Michigan City
mi
from
Michigan City, IN
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
McFarland Clinic PC-William R Bliss Cancer Center
mi
from
Ames, IA
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
McFarland Clinic PC-William R Bliss Cancer Center
mi
from
Ames, IA
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Medical Oncology and Hematology Associates-West Des Moines
mi
from
Clive, IA
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Medical Oncology and Hematology Associates-West Des Moines
mi
from
Clive, IA
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Iowa-Wide Oncology Research Coalition NCORP
mi
from
Des Moines, IA
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Iowa-Wide Oncology Research Coalition NCORP
mi
from
Des Moines, IA
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Medical Oncology and Hematology Associates-Des Moines
mi
from
Des Moines, IA
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Medical Oncology and Hematology Associates-Des Moines
mi
from
Des Moines, IA
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Medical Oncology and Hematology Associates-Laurel
mi
from
Des Moines, IA
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Medical Oncology and Hematology Associates-Laurel
mi
from
Des Moines, IA
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Siouxland Regional Cancer Center
mi
from
Sioux City, IA
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Siouxland Regional Cancer Center
mi
from
Sioux City, IA
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Saint Luke's Regional Medical Center
mi
from
Sioux City, IA
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Saint Luke's Regional Medical Center
mi
from
Sioux City, IA
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Wichita NCI Community Oncology Research Program
mi
from
Wichita, KA
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Wichita NCI Community Oncology Research Program
mi
from
Wichita, KA
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Johns Hopkins University-Sidney Kimmel Cancer Center
mi
from
Baltimore, MD
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Johns Hopkins University-Sidney Kimmel Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Saint Mary Mercy Hospital
mi
from
Livonia, MI
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Saint Mary Mercy Hospital
mi
from
Livonia, MI
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Saint Joseph Mercy Oakland
mi
from
Pontiac, MI
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Saint Joseph Mercy Oakland
mi
from
Pontiac, MI
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Essentia Health Cancer Center
mi
from
Duluth, MN
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Essentia Health Cancer Center
mi
from
Duluth, MN
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Minnesota Oncology Hematology PA-Maplewood
mi
from
Maplewood, MN
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Minnesota Oncology Hematology PA-Maplewood
mi
from
Maplewood, MN
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Hennepin County Medical Center
mi
from
Minneapolis, MN
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Hennepin County Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Metro Minnesota Community Oncology Research Consortium
mi
from
Saint Louis Park, MN
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Metro Minnesota Community Oncology Research Consortium
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Minnesota Oncology and Hematology PA-Woodbury
mi
from
Woodbury, MN
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Minnesota Oncology and Hematology PA-Woodbury
mi
from
Woodbury, MN
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Nebraska Cancer Research Center
mi
from
Lincoln, NE
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Nebraska Cancer Research Center
mi
from
Lincoln, NE
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Alegent Health Immanuel Medical Center
mi
from
Omaha, NE
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Alegent Health Immanuel Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated:  8/18/2016
Rutgers New Jersey Medical School
mi
from
Newark, NJ
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma
Status: Enrolling
Updated: 8/18/2016
Rutgers New Jersey Medical School
mi
from
Newark, NJ
Click here to add this to my saved trials